HIV induces Gli Proteins to skew naive CD4+ T cells to Th1 and TGF-b effectors
HIV induces Gli Proteins to skew naive CD4+ T cells to Th1 and TGF-b effectors
批准号:
7860422
负责人:
Christel H. Uittenbogaart
金额:
$19.25万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-05 至 2012-05-31
关键词:
Antiviral AgentsApoptosisApoptoticAutoimmunityBindingBinding SitesCD4 Positive T LymphocytesCellsCharacteristicsChronicCommunicable DiseasesDataDiseaseDown-RegulationGLI Family ProteinGLI2 geneGenesGenetic TranscriptionGliomaGoalsHIVHIV Envelope Protein gp120HIV InfectionsHIV-1HumanHuman T-lymphotropic virus 1ImmuneImmune systemImmunologyImmunosuppressionImmunosuppressive AgentsInfectionInflammatoryKnowledgeLeadLinkMalignant NeoplasmsMediatingMultiple SclerosisOpportunistic InfectionsPathway interactionsProteinsRoleT cell differentiationT-LymphocyteTh1 CellsViralViral PathogenesisViral ProteinsVirusbasecell mediated immune responsecytokinegenetic regulatory proteinimmune activationpromoterprotein activationpublic health relevanceresponsetat Proteintherapeutic targettranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Generalized immune activation and apoptosis are key characteristics of progressive HIV-1 disease. HIV-1 Tat protein has been linked to skewing of naive T-cell differentiation and apoptosis; however, the exact mechanisms are not clearly defined. The GLI transcription factors are important regulatory proteins that are involved in cellular differentiation, proliferation, apoptosis, and gene transcription. We have discovered putative GLI binding sites in several pro-inflammatory and pro-apoptotic genes. Our proposal focuses on Tbx21 (Tbet) and TGF-21. Based on these data our overall hypothesis is that HIV-1 infection induces GLI protein activation to turn on immune specific genes that induce generalized immune activation and subsequent apoptosis. Furthermore, we hypothesize that HIV-1 Tat induces TGF-21 transcription by binding to GLI2 at the TGF-21 promoter. The goal of this proposal is to further elucidate the mechanisms whereby HIV-1 activates the human GLI transcription factors to induce transcription of genes responsible for immune activation and apoptosis. Specifically, we intend: 1. To elucidate the mechanisms by which HIV-1 modulates Gli transcription factors to induce Tbx21 (Tbet) gene leading to a pro-inflammatory Th1 response. 2. To investigate how HIV-1 Tat interacts with the cellular transcription factors GLI2/3 to induce the pleiotropic cytokine TGF-21, which can skew CD4+ T-cell differentiation and/or apoptosis. The answers to these questions will undoubtedly lead to increased knowledge of viral pathogenesis and general immunology. These unknown pathways would also be worthwhile therapeutic targets to disable the virus' ability to induce generalized immune activation and bystander apoptosis. The implications of understanding how TGF-21 is transcriptionally regulated are not exclusively pertinent to HIV-1 disease. This pleiotropic immunosuppressive and pro-apoptotic cytokine has key roles in other infectious diseases, autoimmunity, and cancer (HTLV-I, multiple sclerosis, gliomas, etc.). PUBLIC HEALTH RELEVANCE: Immune suppression is a key characteristic of progressive HIV-1 disease. The persistent down-regulation of antiviral cell-mediated responses and increase of immunoregulatory T-cells during chronic HIV infection disables the immune system's control over viral replication as well as opportunistic infections. The viral proteins HIV gp120 and Tat have been attributed to this immunosuppression, but the underlying mechanisms have not been clearly defined. We have recently found that the glioma (Gli) transcription factors are important in the induction the Tbet protein which is essential in cell-mediated immune response, and that HIV-1 inhibits Gli activity. The goal of this proposal is to further elucidate the mechanisms whereby HIV-1 modulates the human Gli transcription factors to skew T-cell differentiation away from antiviral Th1 cells toward immunosuppressive T-cells. The answers to these questions will undoubtedly lead to increased knowledge of viral pathogenesis and general immunology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
55th Midwinter Conference of Immunologists
-
批准号:9053973
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2015
-
负责人:Christel H. Uittenbogaart
-
依托单位:
T follicular regulatory cells, a potential HIV reservoir.
-
批准号:8927527
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2014
-
负责人:Christel H. Uittenbogaart
-
依托单位:
T follicular regulatory cells, a potential HIV reservoir.
-
批准号:8730975
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2014 Midwinter Conference of Immunologists at Asilomar
-
批准号:8651771
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2013
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2014 Midwinter Conference of Immunologists at Asilomar
-
批准号:8975097
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2013
-
负责人:Christel H. Uittenbogaart
-
依托单位:
HIV-induced immune activation impairs immune reconstitution through S1P
-
批准号:8502423
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2012
-
负责人:Christel H. Uittenbogaart
-
依托单位:
HIV-induced immune activation impairs immune reconstitution through S1P
-
批准号:8411112
-
项目类别:
-
资助金额:$22.3万
-
财政年份:2012
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2010 Midwinter Conference of Immunologists at Asilomar
-
批准号:8011995
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2010
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2010 Midwinter Conference of Immunologists at Asilomar
-
批准号:7916313
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2010
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:8138256
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2010
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2010 Midwinter Conference of Immunologists at Asilomar
-
批准号:8230615
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2010
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:8447034
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
HIV induces Gli Proteins to skew naive CD4+ T cells to Th1 and TGF-b effectors
-
批准号:7760028
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:7686052
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:8050537
-
项目类别:
-
资助金额:$34.42万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:8245179
-
项目类别:
-
资助金额:$34.42万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
IFN-a and pDC in HIV infection: impact on T cell development and reconstitution
-
批准号:7788819
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2009
-
负责人:Christel H. Uittenbogaart
-
依托单位:
Conditional live HIV-1 variant to study immune activation and pathogenesis.
-
批准号:7230733
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2007
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2007 Midwinter Conference of Immunologists at Asilomar
-
批准号:7563245
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2007
-
负责人:Christel H. Uittenbogaart
-
依托单位:
2007 Midwinter Conference of Immunologists at Asilomar
-
批准号:7268368
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2007
-
负责人:Christel H. Uittenbogaart
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: